Receiving the COVID-19 vaccine and booster reduced preeclampsia risk by nearly 60% in pregnant patients with preexisting morbidities.

A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.

Health experts are reinforcing the point that full vaccination remains highly effective against severe illness and death caused by COVID-19 as federal regulators consider the possibility of ...

COVID-19 vaccination during pregnancy may lower the risk for preeclampsia and other complications, according to new data.The findings “support the importance of strengthening COVID vaccination ...

A third dose of the Pfizer vaccine is currently authorized for Americans who received their second dose at least six months ago and are ages 65 and older, have a job that increases their risk of ...

HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online Feb. 18 in eClinicalMedicine.

COVID-19 cases and hospitalizations are on the rise again ahead of the busy holiday travel season. Dr. Eric Cioe-Peña joins CBSN to discuss what this means for families planning to gather this ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Experts at the National Comprehensive Cancer Network (NCCN) have now issued an updated ...

Novavax on Wednesday received Food and Drug Administration authorization for a booster dose of its COVID-19 vaccine. Yet unlike the bivalent mRNA vaccines currently on the market, Novavax’s booster ...

Pfizer CEO Albert Bourla appeared on ABC's "This Week." Pfizer CEO Albert Bourla said on ABC's "This Week" Sunday it's possible to provide both COVID-19 booster shots as well as doses for people who ...

There’s been quite a bit of news about COVID-19 booster shots lately, and it’s been more confusing than reassuring. Public health officials don’t agree on whether everyone needs a booster yet, and in ...